中东和非洲放射性药物市场预测至 2028 年 - COVID-19 影响和区域分析（按类型（诊断核医学和治疗核医学）、应用（肿瘤学、心脏病学、神经学等）和最终用户（医院、影像中心、学术和研究中心等）

市场介绍

MEA放射性药物市场是根据沙特阿拉伯、阿联酋、南非和MEA其他地区进行分析的。沙特阿拉伯是该地区最大的市场之一。沙特阿拉伯王国（KSA）中风的患病率显着增加，成为沙特阿拉伯疾病和死亡的重要原因。然而，与发达国家相比，关于脑卒中的发病率、患病率和社会人口特征的研究仍然不足。缺乏认识预计是由于缺乏在这些特定领域进行适当的研究。在沙特阿拉伯，中风是一个快速增长的问题，也是导致疾病和死亡的主要原因。然而，与发达国家相比，由于缺乏足够的研究，对脑卒中的发病率、患病率和社会人口特征的研究仍然缺乏。在阿拉伯人中，很大一部分中风危险因素是众所周知的可改变因素，例如高血压和糖尿病。死于中风的风险随着年龄的增长而增加，死于脑出血的风险更高。年轻中风占所有中风的6-20%。由于与放射性药物相关的设施不断增加，慢性病患病率不断增加，预计中东和非洲地区的放射性药物市场在预测期内将出现显着增长。

在COVID-19的情况下，中东和非洲地区将受到严重影响尤其是南非。中东国家的社会经济状况也受到了 COVID-19 大流行的广泛影响。然而，各国对新冠肺炎 (COVID-19) 大流行做出了明智的反应，以避免感染传播。与其他地区一样，实行了封锁和社会疏远，削弱了这些趋势，阻碍了工作、正常收入、付款、集市、学校和医疗保健。因此，预计各国遭受了巨大损失，并且仍在努力挽回。封锁广泛影响了该地区的非紧急医疗服务，影响了医疗设备。沙特阿拉伯和阿联酋等国家正在成为该地区的医疗保健目的地。然而，他们的资源依赖于国家。该地区发展中国家的疫苗和其他医疗设施的可用性预计将在几年内为市场提供空间。 COVID-19大流行帮助上述国家增强了能力并展示了其医疗保健服务的能力。在沙特阿拉伯，因常见神经系统疾病就诊的人数减少了 24%。与大流行前相比，整个大流行期间。最显着的例子是脑CT扫描，疫情期间增加了11.3%。急诊科就诊次数减少的主要原因之一是担心仅仅去医院就感染 COVID-19。这些因素可能会对市场增长产生负面影响。

市场概况和动态

MEA放射性药物市场预计将从2021年的3.812亿美元增长到2028年的6.3978亿美元；预计 2021 年至 2028 年复合年增长率为 7.7%。随着 PET 和 SPECT 不断提高疾病检测、定位和表征的准确性，核医学程序的使用正在迅速扩大。 PET 和 SPECT 属于临床环境中使用的核医学放射学方法。据核医学协会称，每年，该地区各国都会使用放射性药物和成像仪器进行数百万次核医学手术，以诊断疾病并提供有针对性的治疗。这些技术还被应用于免疫学、感染学、胃肠病学、心脏病学、肿瘤学、神经病学和精神病学等领域，用于诊断和其他应用。先进的核医学和现代成像设备正在帮助医生以更好的方式、更短的时间诊断疾病。用于 PET/CT 和 SPECT/CT 平台的新型放射性药物的不断开发，用于神经病学和骨科等新型临床应用，以及不同肿瘤分期方法的准确性不断提高，进一步促进了市场增长。 2020年9月，Curium推出了Detectnet，这是一种正电子发射断层扫描（PET）试剂，适用于成人患者生长抑素受体阳性神经内分泌肿瘤（NET）的定位。因此，提高核成像技术质量和功效的技术进步有利于 MEA 放射性药物市场的增长。

关键细分市场

从类型上看，诊断核医学领域在2020年MEA放射性药物市场中占据最大份额。从应用上看，肿瘤学领域在2020年MEA放射性药物市场中占有较大的市场份额。此外，2020 年，基于最终用户，医院部门在 MEA 放射性药物市场中占据了更大的份额。

主要来源和上市公司

准备本 MEA 放射性药物市场报告时提到的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司包括 Advanced Accelerator Applications、Bayer AG、Bracco Imaging SpA、Cardinal Health Inc、Curium、ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.、GENERAL ELECTRIC、Nordion 和 NTP RADIOISOTOPES。

购买报告的理由

了解 MEA 放射性药物市场格局，并确定最有可能保证丰厚回报的细分市场
了解 MEA 放射性药物市场不断变化的竞争格局，保持领先地位
通过识别最有可能销售的细分市场，有效规划 MEA 放射性药物市场的并购和合作伙伴关系
通过对各个细分市场表现的敏锐和全面分析，帮助做出明智的业务决策形成 MEA 放射性药物市场
获取 MEA 地区各个细分市场 2021-2028 年的市场收入预测。

MEA 放射性药物市场细分

MEA 放射性药物市场 -按类型

诊断核医学
- SPECT
- PET
治疗核医学
- α发射体
- β发射体
- 近距离放射治疗同位素

< p>MEA 放射性药物市场 - 按应用

肿瘤学
心脏病学
神经学
其他

MEA 放射性药物市场 - 按最终用户划分

医院
影像中心
学术和研究中心 ;
其他

MEA放射性药物市场 - 按国家划分

沙特阿拉伯
南非
阿联酋
MEA 其余地区

MEA 放射性药物市场 - 公司简介

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 MEA Radiopharmaceuticals Market – By Type

1.3.2 MEA Radiopharmaceuticals Market – By Application

1.3.3 MEA Radiopharmaceuticals Market – By End User

1.3.4 MEA Radiopharmaceuticals Market– By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. MEA Radiopharmaceuticals Market– Market Landscape

4.1 Overview

4.2 MEA PEST Analysis

4.3 Experts Opinion

5. MEA Radiopharmaceuticals Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Escalation in the Usage of Alpha Radio Immunotherapy

5.1.2 Surging Advancements in Nuclear Imaging Techniques

5.2 Market Restraints

5.2.1 Accessibility of Substitutes

5.3 Market Opportunities

5.3.1 Growth Potential in Several Countries

5.4 Future Trends

5.4.1 Burgeoning Usage of Nuclear Medicines for Personalized Treatment

5.5 Impact Analysis

6. Radiopharmaceuticals Market– MEA Analysis

6.1 MEA Radiopharmaceuticals Market Revenue Forecast and Analysis

7. MEA Radiopharmaceuticals Market Analysis – By Type

7.1 Overview

7.2 MEA Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

7.3 Diagnostic Nuclear Medicine

7.3.1 Overview

7.3.2 Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 SPECT

7.3.3.1 Overview

7.3.3.2 SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 PET

7.3.4.1 Overview

7.3.4.2 PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Therapeutic Nuclear Medicine

7.4.1 Overview

7.4.2 Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3 Alpha Emitters

7.4.3.1 Overview

7.4.3.2 Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4 Beta Emitters

7.4.4.1 Overview

7.4.4.2 Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5 Brachytherapy Isotopes

7.4.5.1 Overview

7.4.5.2 Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8. MEA Radiopharmaceuticals Market Analysis – By Application

8.1 Overview

8.2 MEA Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

8.3 Oncology

8.3.1 Overview

8.3.2 Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Cardiology

8.4.1 Overview

8.4.2 Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Neurology

8.5.1 Overview

8.5.2 Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9. MEA Radiopharmaceuticals Market Analysis – By End User

9.1 Overview

9.2 MEA Radiopharmaceuticals Market Share, by End User, 2021 and 2028, (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Imaging Centres

9.4.1 Overview

9.4.2 Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Centers

9.5.1 Overview

9.5.2 Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10. MEA Radiopharmaceuticals Market – Country Analysis

10.1 MEA: Radiopharmaceuticals Market

10.1.1 Overview

10.1.2 MEA: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

10.1.2.1 Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1 Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.2 Saudi Arabia Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2.1 Saudi Arabia: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.2.2 Saudi Arabia: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.3 Saudi Arabia Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.4 Saudi Arabia Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.1.2.2 UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1 UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.2 UAE Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2.1 UAE: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.2.2 UAE a: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.3 UAE Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.4 UAE Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.3 South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1 South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.2 South Africa Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.1 South Africa: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.2.2 South Africa: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.3 South Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.4 South Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.4 Rest of MEA: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.1 Rest of MEA: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.2 Rest of MEA Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2.1 Rest of MEA: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.2.2 Rest of MEA: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.3 Rest of MEA Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.4 Rest of MEA Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

11. Impact Of COVID-19 Pandemic on MEA Radiopharmaceuticals Market

11.1 MEA: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Inorganic Growth Strategies

12.2.1 Overview

12.3 Organic Growth Strategies

12.3.1 Overview

13. Company Profiles

13.1 Cardinal Health Inc

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Curium

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GENERAL ELECTRIC

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Bayer AG

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Bracco Imaging S.p.A

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Nordion

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 NTP RADIOISOTOPES

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Advanced Accelerator Applications

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. MEA Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Table 2. Saudi Arabia Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 3. Saudi Arabia Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 4. Saudi Arabia Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 5. Saudi Arabia Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 6. Saudi Arabia Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 7. UAE Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8. UAE Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 9. UAE Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 10. UAE Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 11. UAE Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12. South Africa Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 13. South Africa Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 14. South Africa Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 15. South Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 16. South Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17. Rest of MEA Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 18. Rest of MEA Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 19. Rest of MEA Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 20. Rest of MEA Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 21. Rest of MEA Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 22. Recent Inorganic Growth Strategies

Table 23. Recent Organic Growth Strategies

Table 24. Glossary of Terms

LIST OF FIGURES

Figure 1. MEA Radiopharmaceuticals Market Segmentation

Figure 2. MEA Radiopharmaceuticals Market Segmentation, By Country

Figure 3. MEA Radiopharmaceuticals Market Overview

Figure 4. Diagnostic Nuclear Medicine Segment Held the Largest Share of the Market in 2021

Figure 5. Saudi Arabia to Show Significant Growth During Forecast Period

Figure 6. MEA PEST Analysis

Figure 7. MEA Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints

Figure 8. MEA Radiopharmaceuticals Market– Revenue Forecast and Analysis

Figure 9. MEA Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

Figure 10. MEA Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. MEA SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. MEA PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. MEA Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. MEA Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. MEA Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. MEA Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. MEA Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

Figure 18. MEA Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. MEA Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. MEA Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. MEA Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. MEA Radiopharmaceuticals Market Share, by End User, 2021 and 2028 (%)

Figure 23. MEA Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. MEA Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. MEA Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. MEA Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. MEA: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)

Figure 28. MEA: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

Figure 29. Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 30. UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31. South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32. Rest of MEA: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33. Impact of COVID-19 Pandemic in MEA Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA radiopharmaceuticals market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the MEA radiopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the radiopharmaceuticals market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S..	May 2022
Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En..	May 2022
Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

中东和非洲放射性药物市场预测至 2028 年 - COVID-19 影响和区域分析（按类型（诊断核医学和治疗核医学）、应用（肿瘤学、心脏病学、神经学等）和最终用户（医院、影像中心、学术和研究中心等）

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample